Profiling gene expression in human placentae of different gestational ages: An OPRU network and UW SCOR study

Reproductive Sciences

Volumn 15, Issue 9, 2008, Pages 866-877

  Mikheev, Andrei M ^a   Nabekura, Tomohiro ^a   Kaddoumi, Amal ^a   Bammler, Theo K ^a   Govindarajan, Rajgopal ^a   Hebert, Mary F ^a   Unadkat, Jashvant D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Gestational age; Metabolizing enzymes; Microarray; Placenta; Wnt pathway; Xenobiotic transporters

Indexed keywords

AMINO ACID; BETA CATENIN; CARBOHYDRATE; DNA; WNT PROTEIN;

AMINO ACID METABOLISM; ARTICLE; CARBOHYDRATE METABOLISM; CELL CYCLE; CONTROLLED STUDY; DATA BASE; DNA METABOLISM; FIRST TRIMESTER PREGNANCY; GENE CONTROL; GENE EXPRESSION; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; MICROARRAY ANALYSIS; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GESTATIONAL AGE; HUMANS; PLACENTA; PREGNANCY; RNA, MESSENGER;

EID: 57449110735     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719108322425     Document Type: Article

References (30)

1. Cross JC Placental function in development and disease. Reprod Fertil Dev. 2006 ; 18: 71-76.
2. Pardi G., Cetin I. Human fetal growth and organ development: 50 years of discoveries. Am J Obstet Gynecol. 2006 ; 194: 1088-1099.
3. Unadkat JD, Dahlin A., Vijay S. Placental drug transporters. Curr Drug Metab. 2004 ; 5: 125-131.
4. Carney EW, Scialli AR, Watson RE, DeSesso JM Mechanisms regulating toxicant disposition to the embryo during early pregnancy: an interspecies comparison. Birth Defects Res C Embryo Today. 2004 ; 72: 345-360.
5. Irizarry RA, Hobbs B., Collin F., et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003 ; 4: 249-264.
6. Zeeberg BR, Feng W., Wang G., et al. GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol. 2003 ; 4: R28.
7. Ashburner M., Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000 ; 25: 25-29.
8. Athanassiou M., Hu Y., Jing L., Houle B., Zarbl H., Mikheev AM Stabilization and reactivation of the p53 tumor suppressor protein in nontumorigenic revertants of HeLa cervical cancer cells. Cell Growth Differ. 1999 ; 10: 729-737.
9. Ma FY, Anderson GM, Gunn TD, Goffin V., Grattan DR, Bunn SJ Prolactin specifically activates signal transducer and activator of transcription 5b in neuroendocrine dopaminergic neurons. Endocrinology. 2005 ; 146: 5112-5119.
10. Biola A., Lefebvre P., Perrin-Wolff M., Sturm M., Bertoglio J., Pallardy M. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1. Mol Endocrinol. 2001 ; 15: 1062-1076.
11. Takeda T., Kurachi H., Yamamoto T., et al. Participation of JAK, STAT and unknown proteins in human placental lactogen-induced signaling: a unique signaling pathway different from prolactin and growth hormone. J Endocrinol. 1997 ; 153: R1 - R3.
12. Gonzalez-Sancho JM, Aguilera O., Garcia JM, et al. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer. Oncogene. 2005 ; 24: 1098-1103.
13. Eberhart CG, Argani P. Wnt signaling in human development: beta-catenin nuclear translocation in fetal lung, kidney, placenta, capillaries, adrenal, and cartilage. Pediatr Dev Pathol. 2001 ; 4: 351-357.
14. Adams RH, Porras A., Alonso G., et al. Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol Cell. 2000 ; 6: 109-116.
15. Barak Y., Nelson MC, Ong ES, et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell. 1999 ; 4: 585-595.
16. Cross JC, Baczyk D., Dobric N., et al. Genes, development and evolution of the placenta. Placenta. 2003 ; 24: 123-130.
17. Rossant J., Cross JC Placental development: lessons from mouse mutants. Nat Rev Genet. 2001 ; 2: 538-548.
18. Chan CC, Lao TT, Cheung AN Apoptotic and proliferative activities in first trimester placentae. Placenta. 1999 ; 20: 223-227.
19. Gheorghe C., Mohan S., Longo LD Gene expression patterns in the developing murine placenta. J Soc Gynecol Investig. 2006 ; 13: 256-262.
20. Zhou Y., McMaster M., Woo K., et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol. 2002 ; 160: 1405-1423.
21. Shibuya M., Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res. 2006 ; 312: 549-560.
22. Leach L., Babawale MO, Anderson M., Lammiman M. Vasculogenesis, angiogenesis and the molecular organisation of endothelial junctions in the early human placenta. J Vasc Res. 2002 ; 39: 246-259.
23. Moon RT Wnt/beta-catenin pathway. Sci. STKE, 2005, 2005: p. cm1.
24. Pinto D., Clevers H. Wnt, stem cells and cancer in the intestine. Biol Cell. 2005 ; 97: 185-196.
25. Goodwin AM, D'Amore PA Wnt signaling in the vasculature. Angiogenesis. 2002 ; 5: 1-9.
26. Pollheimer J., Loregger T., Sonderegger S., et al. Activation of the canonical wingless/T-cell factor signaling pathway promotes invasive differentiation of human trophoblast. Am J Pathol. 2006 ; 168: 1134-1147.
27. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell. 2006 ; 127: 469-480.
28. Brown LM, Lacey HA, Baker PN, Crocker IP E-cadherin in the assessment of aberrant placental cytotrophoblast turnover in pregnancies complicated by pre-eclampsia. Histochem Cell Biol. 2005 ; 124: 499-506.
29. Hemberger M., Cross JC, Ropers HH, Lehrach H., Fundele R., Himmelbauer H. UniGene cDNA array-based monitoring of transcriptome changes during mouse placental development. Proc Natl Acad Sci U S A. 2001 ; 98: 13126-13131.
30. Winn VD, Haimov-Kochman R., Paquet AC, et al. Gene expression profiling of the human maternal-fetal interface reveals dramatic changes between midgestation and term. Endocrinology. 2007 ; 148: 1059-1079.